On March 10, 2026, from 12:00 p.m. -- 1:30 p.m. ET, in room Key West ABCD at the Hilton Orlando, Avidity will host an industry forum lunch titled "Biomarker Advancements in Rare Neuromuscular Disease: ...
Sarepta Therapeutics CEO Doug Ingram announced Wednesday that he will retire by the end of 2026, citing a “shocking and ...
MedPage Today on MSN
Antibody-Oligonucleotide Conjugate Shows Promise in Myotonic Dystrophy Type 1
Del-desiran reduced DMPK mRNA levels, but led to two serious adverse events ...
Comedian Gilbert Gottfried, shown in a 2016 photo, died on Tuesday, April 12, from recurrent ventricular tachycardia due to myotonic dystrophy type II. Scott Roth Scott Roth/Invision/AP Comedian ...
DUBLIN--(BUSINESS WIRE)--The "Myotonic Dystrophy - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering. The "Myotonic Dystrophy - Pipeline Insight, 2023" report ...
Atrium is led by Kathleen Gallagher, who was chief programme officer at Avidity before it was acquired by Novartis and will ...
The comedian, who died Tuesday at 67, was dealing with "a very specific, rare genetic disorder," cardiologist Dr. Jennifer Haythe tells PEOPLE Julie Mazziotta is the Senior Sports Editor at PEOPLE, ...
Arthex Biotech, a clinical-stage biotechnology company advancing RNA-based therapeutics for neuromuscular disorders, today announced the publication of a peer-reviewed research article entitled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results